Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Wessendorf

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Langenbeck'S Archives of Surgery|January 31, 2002
Early bursting strength of human colon anastomoses--an in vitro study comparing current anastomotic techniquesRobert Schwab, S Wessendorf, A Gutcke, et al.
Annals of Hematology|April 30, 2003
DNA microarray analysis in malignant lymphomasC Schwaenen, S Wessendorf, H A Kestler, et al.
Methods of Information in Medicine|October 17, 2007
Development and implementation of an analysis tool for array-based comparative genomic hybridizationM Kreuz, M Rosolowski, H Berger, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|August 8, 2006
[A new dimension of DNA analysis: genomic profiling by matrix CGH]S Joos, B Radlwimmer, M Nessling, et al.
Annals of Hematology|January 5, 2002
Potential of chromosomal and matrix-based comparative genomic hybridization for molecular diagnostics in lymphomasS Wessendorf, P Lichter, C Schwänen, et al.
Leukemia|August 31, 2007
Further delineation of chromosomal consensus regions in primary mediastinal B-cell lymphomas: an analysis of 37 tumor samples using high-resolution genomic profiling (array-CGH)S Wessendorf, T F E Barth, A Viardot, et al.
Oncogene|November 6, 2007
Detailed mapping of chromosome 17p deletions reveals HIC1 as a novel tumor suppressor gene candidate telomeric to TP53 in diffuse large B-cell lymphomaH Stöcklein, J Smardova, J Macak, et al.
Leukemia|June 27, 2008
Pathway activation patterns in diffuse large B-cell lymphomasS Bentink, S Wessendorf, C Schwaenen, et al.
Scientific Reports|September 8, 2023
Randomized phase-III study of low-dose cytarabine and etoposide + /- all-trans retinoic acid in older unfit patients with NPM1-mutated acute myeloid leukemiaR F Schlenk, D Weber, J Krzykalla, et al.
Journal of Cancer Research and Clinical Oncology|May 26, 2020
Dynamics in treatment response and disease progression of metastatic colorectal cancer (mCRC) patients with focus on BRAF status and primary tumor location: analysis of untreated RAS-wild-type mCRC patients receiving FOLFOXIRI either with or without panitumumab in the VOLFI trial (AIO KRK0109)A Kurreck, M Geissler, U M Martens, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Langenbeck'S Archives of Surgery|January 31, 2002
Early bursting strength of human colon anastomoses--an in vitro study comparing current anastomotic techniquesRobert Schwab, S Wessendorf, A Gutcke, et al.
Annals of Hematology|April 30, 2003
DNA microarray analysis in malignant lymphomasC Schwaenen, S Wessendorf, H A Kestler, et al.
Methods of Information in Medicine|October 17, 2007
Development and implementation of an analysis tool for array-based comparative genomic hybridizationM Kreuz, M Rosolowski, H Berger, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|August 8, 2006
[A new dimension of DNA analysis: genomic profiling by matrix CGH]S Joos, B Radlwimmer, M Nessling, et al.
Annals of Hematology|January 5, 2002
Potential of chromosomal and matrix-based comparative genomic hybridization for molecular diagnostics in lymphomasS Wessendorf, P Lichter, C Schwänen, et al.
Leukemia|August 31, 2007
Further delineation of chromosomal consensus regions in primary mediastinal B-cell lymphomas: an analysis of 37 tumor samples using high-resolution genomic profiling (array-CGH)S Wessendorf, T F E Barth, A Viardot, et al.
Oncogene|November 6, 2007
Detailed mapping of chromosome 17p deletions reveals HIC1 as a novel tumor suppressor gene candidate telomeric to TP53 in diffuse large B-cell lymphomaH Stöcklein, J Smardova, J Macak, et al.
Leukemia|June 27, 2008
Pathway activation patterns in diffuse large B-cell lymphomasS Bentink, S Wessendorf, C Schwaenen, et al.
Scientific Reports|September 8, 2023
Randomized phase-III study of low-dose cytarabine and etoposide + /- all-trans retinoic acid in older unfit patients with NPM1-mutated acute myeloid leukemiaR F Schlenk, D Weber, J Krzykalla, et al.
Journal of Cancer Research and Clinical Oncology|May 26, 2020
Dynamics in treatment response and disease progression of metastatic colorectal cancer (mCRC) patients with focus on BRAF status and primary tumor location: analysis of untreated RAS-wild-type mCRC patients receiving FOLFOXIRI either with or without panitumumab in the VOLFI trial (AIO KRK0109)A Kurreck, M Geissler, U M Martens, et al.
Pageof 1